Home/Votes/U.S. Senate roll call 103
U.S. Senate · recorded vote · Apr 23, 2026

To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.

On the Amendment · Amendment Rejected

48Yea
50Nay
2Not voting
Member-level record

How every member voted

OFFICIAL XML

Published vote labels are reproduced without scoring or interpretation. “Not voting” does not state why a member did not cast a recorded vote.

MemberPartyStateVote
Jim BanksRINNay
Rand PaulRKYNay
Ted BuddRNCNay
Graham (R-SC)RSCNay
Tim ScottRSCNay
Ted CruzRTXNay
Mike LeeRUTNay
Chuck GrassleyRIANot voting
Mark R. WarnerDVANot voting
Andy KimDNJYea
Ron WydenDORYea
Jack ReedDRIYea
Tim KaineDVAYea